AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 45(3), 1991, pp. 360-365
Copyright © 1991 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Homeida, M. A.
Right arrow Articles by Bennett, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Homeida, M. A.
Right arrow Articles by Bennett, J. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cirrhosis

Association of the Therapeutic Activity of Praziquantel with the Reversal of Symmers' Fibrosis Induced by Schistosoma mansoni

Mamoun A. Homeida, Isam El Tom, Theodore Nash AND James L. Bennett
Departments of Medicine and Pathology, Faculty of Medicine, University of Khartoum, Khartoum, Sudan; Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, Maryland; Department of Pharmacology/Toxicology, Michigan State University, East Lansing, Michigan

The impact of antischistosomal chemotherapy on the most important complication of intestinal schistosomiasis, Symmers' periportal fibrosis, has not been determined. Since abdominal ultrasonography has proven to be an effective tool in assessing the extent of Symmers' fibrosis in patients, we monitored the effect of chemotherapy, which involved the annual administration of praziquantel, on 48 Sudanese villagers having varying degrees of Symmers' fibrosis. Results indicate no significant differences in the fibrotic status of the 48 patients between 1986 and 1987, but test statistics (both the Wilcoxon signed rank test and Friedman's block/treatment test), indicated a significant decrease between the fibrotic status of the patients in 1986 and their fibrotic status in 1988 and 1989. Thus, after three years of therapy, 12 of the 48 patients no longer had detectable Symmers' fibrosis, while another 16 patients experienced a reduction in the amount of fibrosis in their livers. When coupled with our previous study, which demonstrated that annual treatment of children with praziquantel prevents the appearance of Symmers' fibrosis, it now appears that praziquantel may reverse this schistosomal-induced pathology.




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
P. Martins-Leite, G. Gazzinelli, L. F. Alves-Oliveira, A. Gazzinelli, L. C. C. Malaquias, R. Correa-Oliveira, A. Teixeira-Carvalho, and A. M. S. Silveira
Effect of Chemotherapy with Praziquantel on the Production of Cytokines and Morbidity Associated with Schistosomiasis Mansoni
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2780 - 2786.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
N. Berhe, B. Myrvang, and S. G. Gundersen
Reversibility of Schistosomal Periportal Thickening/Fibrosis after Praziquantel Therapy: A Twenty-Six Month Follow-up Study in Ethiopia
Am J Trop Med Hyg, February 1, 2008; 78(2): 228 - 234.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
G. F. COTA, R. A. PINTO-SILVA, C. M. F. ANTUNES, and J. R. LAMBERTUCCI
ULTRASOUND AND CLINICAL INVESTIGATION OF HEPATOSPLENIC SCHISTOSOMIASIS: EVALUATION OF SPLENOMEGALY AND LIVER FIBROSIS FOUR YEARS AFTER MASS CHEMOTHERAPY WITH OXAMNIQUINE
Am J Trop Med Hyg, January 1, 2006; 74(1): 103 - 107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society of Tropical Medicine and Hygiene.